FDA Approves First Nonopioid Drug for Opioid Withdrawal
The US Food and Drug Administration (FDA) has approved lofexidine hydrochloride (Lucemyra, US WorldMeds), a nonopioid, for the mitigation of symptoms in the setting of abrupt opioid withdrawal in adults.
The approval follows a recommendation for approval back in March by the FDA Psychopharmacologic Drugs Advisory Committee, as reported by Medscape Medical News.
